John P. Hamill - Net Worth and Insider Trading
John P. Hamill Net Worth
The estimated net worth of John P. Hamill is at least $25,113 dollars as of 2026-09-20. John P. Hamill is the SrVP/CFO/Prin Fin & Acct Ofcr of Aprea Therapeutics Inc and owns about 33,433 shares of Aprea Therapeutics Inc (APRE) stock worth over $25,112. John P. Hamill is the VP Fin,Princ Fin&Acct Officer of Trevena Inc and owns about 132 shares of Trevena Inc (TRVN) stock worth over $1. John P. Hamill is also the SVP & CFO of Windtree Therapeutics Inc and owns about 2 shares of Windtree Therapeutics Inc (WINT) stock worth over $0. Details can be seen in John P. Hamill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John P. Hamill has not made any transactions after 2026-01-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John P. Hamill
John P. Hamill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John P. Hamill owns 4 companies in total, including Windtree Therapeutics Inc (WINT) , Trevena Inc (TRVN) , and Cellectar Biosciences Inc (CLRB) among others .
Click here to see the complete history of John P. Hamill’s form 4 insider trades.
Insider Ownership Summary of John P. Hamill
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| WINT | Windtree Therapeutics Inc | 2022-07-26 | SVP & CFO |
| TRVN | Trevena Inc | 2019-05-31 | Int. Prin. Fin. Off. and PAO |
| CLRB | Cellectar Biosciences Inc | 2017-09-05 | Interim CFO |
 | | 2026-01-30 | SrVP/CFO/Prin. Fin &Acctg. Off |
John P. Hamill Latest Holdings Summary
John P. Hamill currently owns a total of 3 stocks. Among these stocks, John P. Hamill owns 33,433 shares of Aprea Therapeutics Inc (APRE) as of January 30, 2026, with a value of $25,112 and a weighting of 99.99%. John P. Hamill owns 132 shares of Trevena Inc (TRVN) as of May 31, 2019, with a value of $1 and a weighting of 0.01%. John P. Hamill also owns 2 shares of Windtree Therapeutics Inc (WINT) as of July 26, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of John P. Hamill
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2026-01-30 | 33,433 | 0.75 | 25,112 |
| TRVN | Trevena Inc | 2019-05-31 | 132 | 0.01 | 1 |
| WINT | Windtree Therapeutics Inc | 2022-07-26 | 2 | 0.00 | 0 |
Holding Weightings of John P. Hamill
John P. Hamill Form 4 Trading Tracker
According to the SEC Form 4 filings, John P. Hamill has made a total of 5 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Aprea Therapeutics Inc is the acquisition of 5,700 shares on January 30, 2026, which cost John P. Hamill around $5,073.
According to the SEC Form 4 filings, John P. Hamill has made a total of 0 transactions in Trevena Inc (TRVN) over the past 5 years. The most-recent trade in Trevena Inc is the acquisition of 12 shares on May 31, 2019, which cost John P. Hamill around $8,700.
According to the SEC Form 4 filings, John P. Hamill has made a total of 1 transactions in Windtree Therapeutics Inc (WINT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Windtree Therapeutics Inc is the acquisition of 0 shares on July 26, 2022, which cost John P. Hamill around $1,110.
Insider Trading History of John P. Hamill
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
John P. Hamill Trading Performance
GuruFocus tracks the stock performance after each of John P. Hamill's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John P. Hamill is -3.56%. GuruFocus also compares John P. Hamill's trading performance to market benchmark return within the same time period. The performance of stocks bought by John P. Hamill within 3 months outperforms 2 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John P. Hamill's insider trading performs compared to the benchmark.
Performance of John P. Hamill
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.64 | | | | | |
| Relative Return to S&P 500(%) | 7.95 | | | | | |
John P. Hamill Ownership Network
Ownership Network List of John P. Hamill
Ownership Network Relation of John P. Hamill
John P. Hamill Owned Company Details
What does Windtree Therapeutics Inc do?
Who are the key executives at Windtree Therapeutics Inc?
John P. Hamill is the SVP & CFO of Windtree Therapeutics Inc. Other key executives at Windtree Therapeutics Inc include director & Chief Executive Officer Craig Fraser , VP & Controller & & CAO Jamie Mcandrew , and 10 percent owner Center Laboratories, Inc. .
Windtree Therapeutics Inc (WINT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Windtree Therapeutics Inc (WINT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Windtree Therapeutics Inc (WINT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Windtree Therapeutics Inc (WINT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Windtree Therapeutics Inc Insider Transactions
John P. Hamill Mailing Address
Above is the net worth, insider trading, and ownership report for John P. Hamill. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, John P. Hamill's mailing address is: Doylestown Pa 18902.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
